Filing Details
- Accession Number:
- 0001179110-15-009170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-04 17:09:27
- Reporting Period:
- 2015-06-02
- Filing Date:
- 2015-06-04
- Accepted Time:
- 2015-06-04 17:09:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1065087 | Albany Molecular Research Inc | AMRI | Services-Commercial Physical & Biological Research (8731) | 141742717 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1449207 | R Steven Hagen | 26 Corporate Circle Albany NY 12203 | Svp Manufacturing & Pharmaceut | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-06-02 | 463 | $0.00 | 30,737 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-06-02 | 1,250 | $0.00 | 29,487 | No | 4 | D | Direct | |
| Common Stock | Acquisiton | 2015-06-02 | 3,750 | $5.25 | 33,237 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-02 | 3,750 | $19.39 | 29,487 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | D | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Acquisiton | 2015-06-02 | 3,750 | $0.00 | 3,750 | $5.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-06-02 | No | 4 | M | Direct |
Footnotes
- Consists of shares withheld by Albany Molecular Research, Inc. in order to satisfy the minimum tax withholding obligation of the reporting person.
- Consists of shares forfeited due to performance conditions having not been met.
- Option grant was fully exercisable June 2, 2015.
Billionaire Hedge Funds
